Generic Clearance for the Collection of Qualitative Feedback on Food and Drug Administration Service Delivery

OMB 0910-0697

The information collected from our customers and stakeholders will help ensure that users have an effective, efficient, and satisfying experience with FDA's programs. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between FDA and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management.

The latest form for Generic Clearance for the Collection of Qualitative Feedback on Food and Drug Administration Service Delivery expires 2023-12-31 and can be found here.

Latest Forms, Documents, and Supporting Material

Document Name
0697 83-C July 2022.docx Justification for No Material/Nonsubstantive Change
0697 OMB Memo Template.docx Supplementary Document
0697 Supporting Statement Part B 2020.docx Supporting Statement B
0697 Supporting Statement Part A 2020.docx Supporting Statement A
Small Group Discussions with Applicants and Other External Stakeholders Regarding Clarity, Understandability, and Usefulness of FDA's Benefit-Risk Framework (BRF) Other-External Discussion Informed Consent
Email Survey Audience Analysis Study (CTP) Other-Protocol
Patient and Caregiver Diversity in FDA Patient Engagement Activities - Interviews (OC) Other-Interview Guide - Patient Advocacy Org.
Educational Outreach Focus Groups with Health Educators (CTP) Other-Initial Email Screener
Strengthening Interactions Between CBER's Office of Tissues and Advanced Therapies and Cell and Gene Therapy Sponsors (CBER) Other-Invitation
Environmental Scan (CVM) Other-Survey Instrument
This is Our Watch Retailer Feedback Study (CTP) Other-Discussion Guide
Assessments of Patient and Patient Advocate Experience with the FDA For Patients Website and Patient Listening Session Program (OC) Other-Interview Guide
Accreditation Scheme for Conformity Assessment Accreditation Body Training Feedback (CDRH) Other-Survey Instrument
Survey to Determine Euthanasia Practices and Use of Pentobarbital Among Veterinarians Practicing in the United States (CVM) Other-Survey Instrument

All Historical Document Collections

202206-0910-016 Approved without change	No material or nonsubstantive change to a currently approved collection	2022-06-30
202011-0910-002 Approved without change	Extension without change of a currently approved collection	2020-11-27
201710-0910-006 Approved without change	Revision of a currently approved collection	2017-11-01
201507-0910-009 Approved without change	No material or nonsubstantive change to a currently approved collection	2015-07-22
201409-0910-017 Approved without change	Extension without change of a currently approved collection	2014-09-24
201105-0910-006 Approved without change	New collection (Request for a new OMB Control Number)	2011-05-26

OMB Details

Survey to Determine Euthanasia Practices and Use of Pentobarbital Among Veterinarians Practicing in the United States (CVM)

Federal Enterprise Architecture: Health - Health Care Services